Armando E. Giuliano, MD, FACS, FRCSEd, Hon. FPCS, FSSO

PCSA Member: 41 years

Biographical Information:

Dr. Armando E. Giuliano currently serves as Chief of Breast Surgical Oncology and Regional Medical Director for Breast Oncology at Cedars-Sinai Medical Center. Additionally, he is Clinical Professor of Surgery at UCLA and an honorary fellow of the Royal College of Surgeons and of the Philippine College of Surgeons. Dr. Giuliano received his MD from the University of Chicago and completed his surgical training at the University of California, San Francisco, followed by a fellowship in surgical oncology at UCLA. He has held numerous academic and leadership positions, including President of both the Society of Surgical Oncology and the International Sentinel Node Society.

Dr. Giuliano is best known for developing and establishing sentinel lymph node biopsy as a standard of care in breast cancer, a transformative innovation that significantly reduced surgical morbidity worldwide. His work has reshaped clinical practice and influenced international guidelines in breast cancer treatment. He currently serves as Vice Chair of the Breast Expert Panel for the Editorial Board for the AJCC Cancer Staging Manual. Dr. Giuliano has authored over 600 publications and trained more than 160 fellows in breast and complex general surgical oncology. He has delivered honorary lectures and visiting professorships across North America, South America, Europe, Asia, and Africa, reflecting his global influence on surgical oncology. His contributions to the field have been recognized with numerous national and international honors including the William L. McGuire Memorial Lecture Award, the St. Gallen Breast Cancer Award, the Prize of the International Society of Surgery, and the Susan G. Komen Brinker Award for Scientific Distinction. Recently the American Surgical Association honored him with the Medallion for the Advancement of Surgical Care.

Dr. Giuliano has played a vital role in advancing clinical research, education, and consensus guidelines in cancer care. He continues to lead multidisciplinary programs, mentor the next generation of surgeons, and contributes to innovations that improve outcomes for patients with breast cancer.

Leadership roles  within PCSA: 

• 1987-88, PCSA Representative, Hsiao RVU Committee
• 2014-20, PCSA Council Representative, American College of Surgeons Board of Governors and Chair, Nominating Committee, Board of Governors, American College of Surgeons